Ozempic - direct healthcare professional communication (DHPC)

semaglutide

About

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Documents

Direct healthcare professional communication (DHPC): Ozempic (semaglutide) solution for injection in pre-filled pen: supply shortage update

Key facts

• Medicine name:
  Ozempic
• Active substance:
  semaglutide
• Therapeutic area (MeSH):
  Diabetes Mellitus
• Procedure number:
  EMEA/H/C/004174
• DHPC type:
  Medicine shortage
• Human ATC codes:
  A10BJ06
• Dissemination date:
  13/03/2023